Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Jacqui Wise
  1. London

    A large prospective follow up of the measles, mumps, and rubella (MMR) vaccination programme in Finland has concluded that serious adverse events are rare and greatly outweighed by the risks of disease. The message is reinforced by two independent advisory bodies in the United Kingdom, which have carried out further reviews of the safety data.

    The Committee on Safety of Medicines and the Joint Committee on Vaccination and Immunisation independently examined all the data in an …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular